Bashing the incompetence of government bureaucrats has become both a popular pastime and a dysfunctional justification for privatizing a variety of government functions. A case in point has been government oversight functions. However, the collapse of ceiling tiles in a Big Dig tunnel in Boston is a vivid reminder of why relying on market forces and financial incentives -without sufficient government oversight -does not work for public programs. As details of the construction emerge, it is increasingly clear that the Commonwealth of Massachusetts made a huge mistake a decade ago when it eliminated ''redundant bureaucracy'' and largely ceded oversight of the project to private sector contractors.
In health policy today, two issues stand out in their need for government oversight: Medicare Part D and rebuilding the public health infrastructure.
Medicare Part D and Pharmaceutical Companies' Profits
To date, Medicare offers a contrasting picture to the Big Dig. We've become more sophisticated at oversight of Medicare reimbursement; the recent proposed rule changes for how Medicare will pay for inpatient care and physician services are good examples of how oversight brings about continual changes and refinements to payments as they become outmoded. However, it is not easy to implement a new program -especially one like Part D, where many risks are unknown.
To encourage a large number of companies to sell the Medicare prescription drug insurance, Congress opted to have the government take responsibility for much of the risk that total drug spending would be higher than was expected by the insuring organizations offering the Part D plans. This strategy worked -most beneficiaries have more than 40 choices for Part D coverage, a far larger number than had been anticipated a year ago.
But now the auditing of these expenditures has to begin. The Medicare Payment Advisory Commission (MedPAC) and the Centers for Medicare and Medicaid Services (CMS) need to have knowledgeable people examine the records of the Part D prescription drug plans to see how the enrollees' drug spending compares with the original expenditure estimates of the organizations.
Pharmaceutical firms are reporting an increased number of prescriptions filled and higher profits for the second quarter of 2006 compared to a year earlier. Industry analysts are saying these increases are due to Part D. This seems too simplistic a conclusion. But it does underscore the need for analysts without financial ties to the pharmaceutical industry to monitor Part D organizations' profits and how these organizations are negotiating prices for drugs. MedPAC and CMS cannot contract for such analyses on the ''cheap.' ' We know from the Big Dig and many other experiences that when government budget pressures reduce oversight activities, the incentives are high for contractors to inflate actual costs. For Medicare Part D, the federal government reinsurance formula is very complex, placing an even greater level of responsibility on the federal oversight function. Unless federal officials can perform a careful audit of drug expenditure records, the cost to taxpayers of the Part D benefit could be far greater than anyone predicted. Given the challenges in ensuring that the federal government does not end up with a disproportionate share of the risk in Medicare Part D, it is critical that sufficient funds be allocated to permit real oversight of the claims experiences of the prescription drug insurance providers.
Rebuilding the Public Health Infrastructure
The federal government has provided block grants to states to be prepared for emergencies due to natural disasters, epidemics and terrorist attacks. The irony -as anyone who recently has encountered delays in a hospital admission knows -is that our public health infrastructure has deteriorated over the past three decades. Not only do we not have sufficient ''surge'' capacity for inpatient care for disasters, but planning for these events has been hampered by responsibility being divided among various federal agencies (e.g., the Centers for Disease Control and Prevention, the Department of Homeland Security).
The deterioration of the public health infrastructure has implications beyond our ability to respond to disasters. It also reduces our ability to tackle population health issues such as the increased incidence of diabetes and obesity. These chronic health problems are becoming the equivalent of the 20 th century's struggle with tuberculosis, childhood diseases, and smoking.
Providing federal block grants to states -and explicitly leaving decisions about rebuilding the public health infrastructure to states -may be useful in the short-run for experimenting. But without a national plan, we will end up with a hodgepodge of state efforts. As Hurricanes Katrina and Rita made perfectly obvious, disasters do not pay attention to state boundaries. We need more government economists and behavioral organization experts involved in setting priorities and payment mechanisms that will lead to an efficient mix of public health preparedness and activities. Without this, the allocation of block grant funding will be driven by responses to lobbying efforts by various providers and other groups, and the incentives for inflating costs will be high.
Government Activities Are Essential
Outsourcing government activities related to oversight and planning for future needs is a bad idea. The mistake in Boston was the decision to shift the government's responsibility to oversee the Big Dig to the contractors in charge of building the project. Markets do not work efficiently when there are significant information asymmetries or uncertainties; these are exactly the conditions where government agencies are needed. This is the message that the public needs to hear -not red herring stories that government is inept.
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